Inhibitory function of interferon on hepatocarcinogenesis.
1Department of Pathology, Kurume University School of Medicine, Kurume, Japan. hiroyano@med.kurume-u.ac.jp
Oncology
|December 19, 2008
Summary
Pegylated interferon (IFN) demonstrated significant antitumor effects against liver cancer cells in vitro and in vivo. This study highlights pegylated IFN
Area of Science:
- Hepatocellular Carcinoma Research
- Interferon Therapy
- Cancer Cell Biology
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Type I interferons (IFNs) are used in treating chronic hepatitis C and have shown potential in cancer therapy.
Purpose of the Study:
- To investigate the growth-inhibitory effects and mechanisms of type I interferons (IFNs) on human liver cancer cells.
- To evaluate the efficacy of different type I IFN preparations in preclinical models.
Main Methods:
- In vitro analysis of five type I IFN preparations (pegylated/nonpegylated IFN-alpha, IFN-beta) on 13 liver cancer cell lines.
- In vivo studies involving subcutaneous administration of IFN preparations to nude mice bearing human liver cancer xenografts.
Main Results:
- IFN-beta exhibited the strongest growth-inhibitory effects in vitro.
- IFN-induced cell cycle arrest and apoptosis were identified as key mechanisms of action.
- Pegylated IFN demonstrated superior antitumor efficacy compared to nonpegylated forms in vivo, with dose-dependent tumor reduction.
Conclusions:
- Type I IFNs, particularly pegylated interferon, show promise for the prevention and treatment of hepatocellular carcinoma.
- Further clinical investigation of pegylated IFN for HCC is warranted based on these preclinical findings.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...